Glioma (U251n), testicular germ cell tumor (TCAM2), epithelial ovarian cancer (ES-2) and oral squamous carcinoma (B88-SDF-1) cells have also been shown to be insensitive to AMD3100 (24,25,28,31). This evidence concerns the gene CXCL12 and glioma.